A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection

Sponsor
Gilead Sciences (Industry)
Overall Status
Completed
CT.gov ID
NCT02292706
Collaborator
(none)
1,609
138
84.1
11.7
0.1

Study Details

Study Description

Brief Summary

This Registry will enroll participants with cirrhosis with or without decompensated liver disease who have achieved a sustained virologic response (SVR) after receiving a sofosbuvir (SOF)-based regimen without interferon (IFN) while participating in a Gilead-sponsored hepatitis C virus (HCV) study or commercially at selected sites. Once enrolled, participants will be followed for up to 5 years.

Condition or Disease Intervention/Treatment Phase

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
1609 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Registry for Subjects With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection
Actual Study Start Date :
Dec 29, 2014
Actual Primary Completion Date :
Dec 31, 2021
Actual Study Completion Date :
Dec 31, 2021

Outcome Measures

Primary Outcome Measures

  1. Proportion of participants maintaining sustained virologic response (SVR) at Week 240 [Week 240]

  2. Proportion of participants who develop liver disease progression or regression, as assessed by clinical and laboratory parameters [Up to 240 weeks]

  3. Proportion of participants who develop hepatocellular carcinoma (HCC) through Week 240 [Up to 240 weeks]

Secondary Outcome Measures

  1. Proportion of participants with detectable HCV RNA due to re-emergence of pre-existing virus through Week 240 [Up to 240 weeks]

  2. Proportion of participants with detectable HCV resistance mutations through Week 240 [Up to 240 weeks]

  3. Proportion of participants with detectable HCV RNA due to re-infection through Week 240 [Up to 240 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Key Inclusion Criteria:
  • Willing and able to provide written informed consent

  • Have either previously participated in a Gilead-sponsored HCV study and received a sofosbuvir-containing regimen without interferon OR at pre-selected sites only, have received an all-oral SOF-based regimen outside a clinical study. These individuals must have documentation of the regimen, start and end of treatment dates (month and year), and of having achieved SVR12.

  • Have achieved SVR either in a Gilead-sponsored study, as defined in the treatment protocol OR for individuals who enroll after receiving an all-oral SOF-based regimen outside a clinical study, SVR will be defined as HCV RNA < LLOQ approximately 12 weeks following last dose of treatment.

  • Have liver cirrhosis, as defined in the treatment protocol, and have not had a liver transplant after receiving a SOF-containing regimen OR individuals who enroll after receiving an all-oral SOF-based regimen outside a clinical study, will have had cirrhosis confirmed prior to initiation of HCV treatment.

Key Exclusion Criteria:
  • Individuals planning to initiate a new course of HCV therapy, including approved products and any investigational agents, during the course of this Registry

  • History of clinically-significant illness or any other major medical disorder that may interfere with the follow-up, assessments, or compliance with the protocol

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Alabama at Birmingham Birmingham Alabama United States
2 Scripps Clinic Medical Group La Jolla California United States
3 V.A. Long Beach Medical Center Long Beach California United States
4 Cedars Sinai Medical Center Los Angeles California United States
5 Kaiser Permanente Medical Center Los Angeles California United States
6 Tarrant County ID Associates Los Angeles California United States
7 The Liver Center Pasadena California United States
8 Inland Empire Liver Foundation Rialto California United States
9 University of California, Davis Medical Center Sacramento California United States
10 Kaiser Permanente San Diego California United States
11 Medical Associates Research Group San Diego California United States
12 Quest Clinical Research San Francisco California United States
13 University of California at San Francisco Medical Center San Francisco California United States
14 Stanford University Stanford California United States
15 University of Colorado Aurora Colorado United States
16 Georgetown University Medical Center Washington District of Columbia United States
17 Whitman-Walker Health Washington District of Columbia United States
18 UF Hepatology Research at CTRB Gainesville Florida United States
19 Borland-Groover Clinic Jacksonville Florida United States
20 University of Miami Miller School of Medicine Miami Florida United States
21 Orlando Immunology Center Orlando Florida United States
22 Tampa General Hospital Tampa Florida United States
23 South Florida Center of Gastroenterology Wellington Florida United States
24 Atlanta Gastroenterology Associates Atlanta Georgia United States
25 Atlanta Medical Center Atlanta Georgia United States
26 Emory University Hospital Midtown Atlanta Georgia United States
27 Gastrointestinal Specialists of Georgia, PC Marietta Georgia United States
28 Northwestern University Chicago Illinois United States
29 Indiana University Indianapolis Indiana United States
30 Indianapolis Gastroenterology Research Foundation Indianapolis Indiana United States
31 University of Kansas Medical Center Research Institute, Inc. Kansas City Kansas United States
32 Delta Research Partners Monroe Louisiana United States
33 Ochsner Clinic Foundation New Orleans Louisiana United States
34 Mercy Medical Center Baltimore Maryland United States
35 Digestive Disease Associates, PA Catonsville Maryland United States
36 Johns Hopkins Hospital/University Lutherville Maryland United States
37 Community Research Initiative of New England Boston Massachusetts United States 02129
38 BIDMC Liver Center Boston Massachusetts United States 02215
39 University of Michigan Medical Center Ann Arbor Michigan United States
40 Henry Ford Health System Detroit Michigan United States
41 University of Minnesota Medical Center Minneapolis Minnesota United States
42 Mayo Clinic Rochester Minnesota United States
43 Minnesota Gastroenterology, PA Saint Paul Minnesota United States
44 Kansas City Research Institute, LLC Kansas City Missouri United States
45 Saint Louis University Saint Louis Missouri United States
46 ID Care, Inc Hillsborough New Jersey United States 08844
47 Southwest CARE Center Santa Fe New Mexico United States
48 Binghamton Gastroenterology Associates, PC Binghamton New York United States
49 North Shore Health Inc. Manhasset New York United States
50 Columbia University Medical Center New York New York United States
51 Icahn School of Medicine at Mount Sinai New York New York United States
52 New York University Medical Center New York New York United States
53 Weill Cornell Medical College New York New York United States
54 Asheville Gastroenterology Associates, PA Asheville North Carolina United States
55 Carolinas Medical Center Charlotte North Carolina United States
56 Duke University Medical Center Durham North Carolina United States
57 Cumberland Research Associates, LLC Fayetteville North Carolina United States
58 Cleveland Clinic Foundation Cleveland Ohio United States
59 Thomas Jefferson University Hospital Philadelphia Pennsylvania United States
60 University of Pennsylvania Health System Philadelphia Pennsylvania United States
61 University of Pittsburgh Medical Center Philadelphia Pennsylvania United States
62 University of Pittsburgh Medical Center Pittsburgh Pennsylvania United States
63 University Gastroenterology Providence Rhode Island United States 02905
64 Gastroenterology Center of the MidSouth, P.C. Germantown Tennessee United States
65 Nashville Gastrointestinal Specialists, Inc. Nashville Tennessee United States
66 Vanderbilt University Medical Center Nashville Tennessee United States
67 The North Texas Clinical Research Institute Arlington Texas United States
68 Baylor Endocrine Center Dallas Texas United States
69 North Texas Research Institute Dallas Texas United States
70 St. Luke's Episcopal Hospital Houston Texas United States
71 The Texas Liver Institute San Antonio Texas United States
72 Intermountain Medical Center Murray Utah United States
73 INOVA Fairfax Hospital Annandale Virginia United States
74 Bon Secours St. Mary's Hospital of Richmond Newport News Virginia United States
75 Digestive and Liver Disease Specialists Norfolk Virginia United States
76 Harborview Medical Center Seattle Washington United States
77 Virginia Mason Medical Center Seattle Washington United States
78 Royal Prince Alfred Hospital Camperdown New South Wales Australia
79 Kirby Institute Sydney New South Wales Australia
80 Westmead Hospital Westmead New South Wales Australia
81 Royal Brisbane & Women's Hospital Herston Queensland Australia
82 Princess Alexandra Hospital Woolloongabba Queensland Australia
83 St Vincents Hospital Sydney Fitzroy Victoria Australia
84 Austin Health Heidelberg Victoria Australia 3084
85 Monash Medical Centre Clayton Campus Melbourne Victoria Australia
86 The Alfred Hospital Prahran Victoria Australia
87 Fiona Stanley Hospital Fremantle Western Australia Australia
88 Royal Perth Hospital Perth Western Australia Australia
89 University of Calgary Calgary Alberta Canada
90 GI Research Institute Vancouver British Columbia Canada
91 Vancouver Infectious Disease Research and Care Centre Vancouver British Columbia Canada
92 London Health Sciences Centre - University Campus London Ontario Canada
93 University Health Network Toronto Ontario Canada
94 CRCHUM Montréal Quebec Canada
95 University of Alberta Edmonton Canada T6G 2B7
96 Hôpital Pontchaillou Rennes Bretagne France
97 Hopital de La Pitié-Salpêtrière Paris Ile De France France
98 CHU Montpellier - Hopital St. Eloi Montpellier Cedex 05 Languedoc-Rousillon France
99 Hôpital Universitaire Dupuytren Limoges Cedex Limousin France
100 Hopital Purpan Toulouse Midi-Pyrenees France
101 Hopital Saint Joseph Marseille Cedex 08 Provence Alpes Cote D'Azur France
102 Groupe Hospitalier Archet I Et II Nice Cedex 3 Provence Alpes Cote D'Azu France 06202
103 Hopital Haut Leveque Bordeaux France
104 CHU Estaing Clermont Ferrand France
105 Hôpital Beaujon Clichy France
106 Hopital Henri Mondor Creteil Cedex France
107 CHU de Grenoble- Hopital Michallon Grenoble Cedex 9 France
108 Hopital Cochin Paris, Cedex 14 France
109 Hopital Tenon Paris France
110 Hôpital de la Croix Rousse Paris France
111 Hôpitaux Universitaires de Strasbourg Strasbourg France
112 CHU de Nancy-Hopital Brabois Adulte Vandoeuvre les Nancy France
113 Hôpital Paul Brousse Villejuif France
114 Klinikum der Johann Wolfgang Goethe Universitat Frankfurt am Main Germany
115 Universitätsklinikum Hamburg-Eppendorf Hamburg Germany 20251
116 Asklepios Klinik St. Georg Hamburg Germany
117 Universitatsklinikum Koln Koln Germany
118 Technische Universität München Mücheln Germany
119 Azienda Ospedaliera Ospedale Niguarda Cà Granda Milano Italy
120 Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milano Italy
121 Ospedale Casa Sollievo Della Sofferenza IRCCS San Giovanni Rotondo Italy
122 Azienda Ospedaliera Città della Salute e della Scienza di Torino Torino Italy
123 Auckland Clinical Studies Ltd Auckland North Island New Zealand
124 Waikato Hospital Hamilton North Island New Zealand
125 Christchurch Hospital Christchurch South Island New Zealand
126 Fundacion de Investigation de Diego San Juan Puerto Rico 00927
127 Hospital Universitario Puerta de Hierro Majadahonda Majadahonda Madrid Spain
128 Hospital Clinic de Barcelona Barcelona Spain 08028
129 Hospital Universitario Vall d'Hebron Barcelona Spain 08035
130 Hospital Virgen de Valme Sevilla Spain
131 Hospital Universitari i Politecnic La Fe de Valencia Valencia Spain
132 Barts Health NHS Trust London England United Kingdom
133 Kings College Hospital London England United Kingdom
134 St Georges University of London London England United Kingdom
135 North Manchester General Hospital Manchester England United Kingdom
136 Nottingham University Hospitals NHS Trust Nottingham England United Kingdom
137 Gartnavel General Hospital Glasgow Scotland United Kingdom
138 Queen Alexandra Hospital Portsmouth United Kingdom

Sponsors and Collaborators

  • Gilead Sciences

Investigators

  • Study Director: Gilead Study Director, Gilead Sciences

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Gilead Sciences
ClinicalTrials.gov Identifier:
NCT02292706
Other Study ID Numbers:
  • GS-US-337-1431
  • 2014-001249-26
First Posted:
Nov 17, 2014
Last Update Posted:
Mar 29, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Keywords provided by Gilead Sciences
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 29, 2022